Media Pack
News

Current Edition

Volume 16 Issue 2
 
Europe

IBD research smashes recruitment target two years early

by Anna Smith Cambridge University Hospital NHS Foundation Trust has announced that its inflammatory bowel disease (IBD) research has hit its recruitment target ...
5 September 2019 Europe | news | North America
Continue Reading →
news

FDA Urges Inclusion Of Men In Breast Cancer Clinical Trials

Men with breast cancer have significantly fewer treatment options than women with the disease, partly due to exclusion from many clinical trials. A new document f...
29 August 2019 news | North America | Regional News
Continue Reading →
news

FDA grants Fast Track designation for Farxiga in chronic kidney disease

AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to dela...
29 August 2019 news | North America | Regional News
Continue Reading →
news

Lilly’s case for Taltz helped by expanded approval

Credit: Eli Lilly & Co. Eli Lilly on Monday won an expanded approval for its psoriasis and arthritis drug Taltz, securing a Food and Drug Administration OK t...
29 August 2019 news | North America | Regional News
Continue Reading →
Europe

AstraZeneca’s Breztri scores in COPD trial, amping its case for triple-combo battle against GSK

Could "orphan drug" status for Fasenra and a Breztri trial win give AstraZeneca a leg up in its battle against GlaxoSmithKline? (AstraZeneca) AstraZeneca and Gla...
29 August 2019 Europe | news | North America | Regional News
Continue Reading →
news

Spurned by FDA a decade ago, Kyowa Kirin wins nod for Parkinson’s drug

Kyowa Kirin has won FDA nod for Nourianz as an add-on treatment to levodopa/carbidopa in adult Parkinson’s disease patients experiencing "off" episodes. (Pixabay/st...
29 August 2019 news | North America | Regional News
Continue Reading →
news

AstraZeneca’s Farxiga pads its case for new heart-helping approval

AstraZeneca's Farxiga showed positive data in reducing cardiovascular risks in a new outcomes trial. (AstraZeneca) AstraZeneca is still stinging after its SGLT2 ...
22 August 2019 news | North America | Regional News
Continue Reading →
Europe

Medicines Co. awaits its date with destiny

Investors in The Medicines Company have Sept. 2 circled in red on their calendars. That's the day the company plans to report the first pivotal results from late-...
22 August 2019 Europe | news | North America | Regional News
Continue Reading →
news

Regeneron gets cholesterol drug win where Praluent won’t go

(Credit: Flickr; Helge V. Keitel ) Regeneron Pharmaceuticals said its experimental drug evinacumab significantly lowered "bad" cholesterol levels 49% compared to...
22 August 2019 news | North America | Regional News
Continue Reading →
news

Roche cancer drug the 3rd approved for pan-tumor use

(Credit: Roche ) For the third time, the Food and Drug Administration cleared a cancer drug to treat tumors based on a specific genetic signature rather than by ...
22 August 2019 news | North America | Regional News
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte